• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Alleviant's Transcatheter Tech Obtains Breakthrough Status

    Signia Appoints New President

    At-Home COVID-19 Test Kits Boosts Disease Monitoring Capabilities

    QT Imaging Signs Distribution Agreement With Freedom Ventures for Breast Scanner

    MedAcuity, Fathom Partner on Human Factors Engineering Services
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Medicoil

    Concise Engineering

    Creganna Medical, part of TE Connectivity

    Element

    PTI Engineered Plastics Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    FUTEK Advanced Sensor Technology Inc.

    maxon

    Concise Engineering

    Spectrum Plastics Group

    Medbio LLC
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    The Value Creation Roadmap for Medical Technology Innovation

    ...

    The Value Creation Roadmap for Medical Technology Innovation
    Related CONTENT
    • CHF Solutions Appoints CEO
    • Freehand Partners with Imperial Medical Solutions
    • Moon Surgical Expands Leadership Team
    • CMS Expedites Breakthrough Device Access; Industry Applauds
    • New Clinical Trial Data Supports BD Libertas Wearable Injector as a Drug Delivery System
    Steve Maylish, Fusion Biotec, and Scott Hutchinson, StoneCreek Capital09.01.17
    Translating clinical research and medical technology innovation into a sustainable company is a complex and far-reaching process. First-time entrepreneurs, clinicians, and engineers often don’t appreciate the importance of the many factors involved—most medical startups fail to commercialize their product and many critical solutions never reach patients. Emerging companies in other sectors face technical and market risks, but medical innovation includes the barriers of regulatory approval, reimbursement, clinical trials, and a complex sales channel strategy.

    A comprehensive strategic and tactical roadmap for medical innovation is key to successful commercialization. The sooner this can start, the better—adhering to a roadmap throughout the funding process largely determines long-term success. Thinking through the complete sequence of ideation, development, approval, and commercialization will help decrease “risk-attracting” capital and increase “smart money.” There are key inflection points and decision tradeoffs to consider along the way. Recognize the elements representing a more comprehensive Medical Technology Value Creation Roadmap when developing a plan—the 12 Roadmap Factors of comprehensive medical technology; identifying risks, key inflection points, and decision tradeoffs; dealing with the major changes in healthcare market dynamics; and constructing a financing plan with the best chance for success.

    Every medical device startup should build The Roadmap to create value and reduce risk. It highlights the most common factors for success and helps develop a successful business plan:
    1. The clinical need to be addressed or  the problem you are solving
    2. Defining the proposed solution and  how it addresses the clinical need
    3. Can this proposed device solution be developed? Is the technical risk high?
    4. Clinical requirements and options for an optimal regulatory path
    5. Intellectual property and freedom to operate
    6. The total available market, the portion served, and the projected share
    7. The go-to-market path to maximize value creation
    8. Manufacturability and is it scalable?
    9. Reimbursement and payment path
    10. Executive team experience and breadth
    11. A comprehensive business plan
    12. A milestone-based financing strategy
    Each of these is important to understand and represent where investors “risk reduce” startup valuations to protect investments. Valuation may reduce for novel technology without a good pre-clinical model to prove feasibility and if you don’t convey the importance of “first-in-man” clinical trials. A business plan lacking a recurring revenue model or a flawed strategy to obtain a new CPT code may also reduce value. Each Roadmap Factor should include detailed “deep dives” to ferret out and address gaps. These should relate chronologically to the funding process and valuation milestones and highlight key inflection points and decision tradeoffs.

    Most startups understand the presence of risks, but often resources and expertise are limited and sometimes compromises are made or short cuts taken in the name of capital efficiency. Analyzing risks in detail and in light of key inflection points informs better business decisions and tradeoffs.

    To build credibility as a viable medical device company, demonstrate understanding of the unique risks, recognize risk reduction is essential to building value, and have a plan to mitigate these risks. Besides obvious technical risks, there are intellectual property, clinical, regulatory, reimbursement, commercialization, marketing, financing, manufacturability/scalability, business strategy, and executive management team risks. Then, of course, there is always timing.

    We’ve asked many startup CEOs, “knowing what you know now, would you go back and do it over again?” Many say no, partly because unaddressed risks accumulate. Risks must be evaluated, addressed, and retired from the beginning—a continuous and often tedious process. Consider the ophthalmology startup going to clinical trials prematurely and unintentionally injuring patients’ eyes. Eventually, the executive team was ousted and the company re-capitalized.

    Strategic Decision Tradeoffs
    Whether a new regulatory plan, development tradeoff, or business pivot, a strategic decision often affects valuation. Strategic tradeoffs can shorten time to market, but also represent associated risks. Consider the imaging company run by researchers unwilling to hire an experienced CEO. Other examples include:
    • When can the first-in-man trial in the clinical process be achieved? How effective will the solution be in humans vs. the associated health risks? What decisions can be made with limited clinical experience?
    • How extensive must the clinical plan be? What are the critical endpoints?
    • When to freeze a design vs. additional feasibility work?
    • When to transfer company leadership to an experienced commercialization executive team?
    Valuation Milestones
    Performing to milestones increases credibility, but progress is often an iterative, discovery process with unpredictable outcomes. Investors understand this, but executive teams may not. A roadmap must accommodate these detours. Realistic gap analysis and achieving valuation milestones aids continued funding tranches. Milestones include defining the clinical need, proposed solution, and value proposition; achieving proof of concept and design freeze; KOL validation; intellectual property—patents filed, freedom to operate, patent issued; FDA approval; and finalizing the market strategy and integrated business plan.

    Medical technology innovators must also consider major shifts in market dynamics. The healthcare industry is transitioning from a fee-for-service payment model to a value-based purchasing model.

    Historically, physicians heavily influenced purchase decisions, fostering a “clinical progress at any price” mentality focused on improving clinical outcomes with little regard to costs. It was successful because fee-for-service payments were based on the physician making the primary purchase decision independent of various payers. As a result, many medical devices came to market with only incremental improvements. This is no longer the case.

    With purchasing decisions shifting from physicians to integrated health systems and other payers, value-based purchasing models are prevalent. A new medical device must clearly demonstrate measurable savings with acceptable or better patient outcomes. Understanding this transition can be a tremendous opportunity to correctly position new devices. Consider the diagnostic company providing early sepsis detection in a point-of-care instrument, preventing non-reimbursable hospital readmissions.

    Medical technology entrepreneurs also face the challenges of securing investment capital. Careful up-front planning to create a financing plan linked to key milestones and risk reduction has the best chance of attracting investment, minimizing dilution, and optimizing value creation. The optimal capital structure determines the amounts and potential sources of financing required during various milestone-based funding tranches. Always develop the plan with a realistic, valuation endpoint in mind.

    The business plan’s pro forma model should define investment amount and timing. Careful structuring in funding tranches around valuation inflection points majorly impacts risk reduction in future financing rounds. For example, achieving first-in-man to shorten the go-to-market time positively affects capital efficiency. Consider the non-invasive body sculpting startup proving feasibility in humans during Series A, reducing its largest risk.

    Including as many Roadmap Factors early in fundraising activities demonstrates understanding of the complete medical innovation process to investors. Once listed chronologically, they can be linked to the various funding stages. All Roadmap Factors should be developed by the C Round.

    Who are the best investors at various company development stages and what are they looking for? Although most startups don’t have the benefit of picking their investors, understanding the various groups’ investment criteria is important to create a financing path. Each has their own benchmarks of when they get involved, expected ROI and ownership percentages, typical investment amounts, and percentage of equity given up at various growth financing stages.

    Develop a plan with the exit in mind and identify milestones that position the company for attractive exit options. There are two types of investors to consider. Strategic investors typically pay a premium and scale the business once validated in the market. Financial buyers, such as private equity funds with defined matrices based on established financial performance history, evaluate your ability to project future financial performance and milestone achievements.

    Focus on Roadmap Factors and associated valuation milestones is warranted in light of frequent startup failures. Strategically addressing these factors lends credibility to an executive team and tactically increases the probability of success. A financing strategy built around a value creation roadmap creates a comprehensive plan for investors. Executive teams build trust and attract capital by understanding the healthcare environment and investor motivation.

    We are passionate about this Roadmap approach based on over three decades of collective experience working with medical innovation companies. Most fail because founders, doctors, or engineers fail to recognize successful medical innovation as more than creating an important solution to an unmet therapeutic or diagnostic need. It requires understanding the full medical technology innovation and commercialization process, including handing over leadership to a commercialization team early. Consider three drug delivery device companies—one which raised $70 million, one that achieved a $300 million public valuation, and one that could not complete a C Round. All three failed primarily because the CEO and Board didn’t understand this Roadmap. Hopefully this approach will be useful to those bringing important new products to market. 


    Steve Maylish has been part of the medical device community for more than 30 years. He is currently chief commercial officer for Fusion Biotec, an Orange, Calif.-based contract engineering firm that brings together art, science, and engineering to create medical devices. Early in his career, Maylish held positions at Fortune 100 corporations such as Johnson & Johnson, Shiley, Sorin Group, Baxter Healthcare, and Edwards Lifesciences.

    Scott Hutchinson has been a financial advisor to growth companies in all aspects of financing, developing, and implementing value creation strategies and M&A for more than 30 years. He has completed approximately 50 transactions representing $600 million and over 50 financial advisory and consulting assignments. Hutchinson is currently focused on helping emerging medical device firms developing important solutions to unmet clinical needs prepare and secure institutional growth capital.
    Related Searches
    • imaging
    • engineering
    • startup
    • development
    Related Knowledge Center
    • R&D & Design
    Suggested For You
    CHF Solutions Appoints CEO CHF Solutions Appoints CEO
    Freehand Partners with Imperial Medical Solutions Freehand Partners with Imperial Medical Solutions
    Moon Surgical Expands Leadership Team Moon Surgical Expands Leadership Team
    CMS Expedites Breakthrough Device Access; Industry Applauds CMS Expedites Breakthrough Device Access; Industry Applauds
    New Clinical Trial Data Supports BD Libertas Wearable Injector as a Drug Delivery System New Clinical Trial Data Supports BD Libertas Wearable Injector as a Drug Delivery System
    FOREFRONT MEDICAL TECHNOLOGY ANNOUNCES UNIQUELY-DESIGNED COVID-19 TEST SWAB FOREFRONT MEDICAL TECHNOLOGY ANNOUNCES UNIQUELY-DESIGNED COVID-19 TEST SWAB
    Finding the Upside to a Challenging Year Finding the Upside to a Challenging Year
    MedAcuity Partners With Loft to Support the Full MedTech Product Development Lifecycle MedAcuity Partners With Loft to Support the Full MedTech Product Development Lifecycle
    First Patient Enrolled in NovaSignal First Patient Enrolled in NovaSignal's Intelligent Ultrasound Clinical Trial
    Avail Medsystems Raises $100 Million in Series B Funding Avail Medsystems Raises $100 Million in Series B Funding
    Mentice to Acquire Vascular Simulations Mentice to Acquire Vascular Simulations
    Medtronic Launches InPen with Real-Time Guardian Connect CGM Data Medtronic Launches InPen with Real-Time Guardian Connect CGM Data
    Alucent Biomedical Closes $35 Million Series B Financing Round Alucent Biomedical Closes $35 Million Series B Financing Round
    Veteran Medical Device Executives Named to Dimension Inx Board  Veteran Medical Device Executives Named to Dimension Inx Board
    Harvard Professor Joins ExThera Medical Board Harvard Professor Joins ExThera Medical Board

    Related Columns

    • Contract Manufacturing | R&D & Design
      Trends for Medtech Contract R&D and Manufacturing

      Trends for Medtech Contract R&D and Manufacturing

      Over the past 10 years, medtech manufacturers from startups to giants have grown their levels of outsourcing to contract R&D and manufacturing partners.
      Maria Shepherd, President and Founder, Medi-Vantage 09.01.20

    • R&D & Design | Surgical
      Sparking Innovation as We Struggle to Find the New Normal

      Sparking Innovation as We Struggle to Find the New Normal

      The goal is to find the best ideas to support orthopedic patients adjusting to additional pain and immobility while they wait for elective surgeries.
      Dawn A. Lissy, Founder & President, Empirical 06.04.20

    • R&D & Design
      Disposable Design: Consider All Interfaces

      Disposable Design: Consider All Interfaces

      The disposable component is becoming more challenging as products get smaller and more complex.
      Will DeMore, Mechanical Engineer, Key Technologies Inc. 06.04.20


    • R&D & Design
      Why Outsourcing Is in: Piecing Out Projects Makes Sense

      Why Outsourcing Is in: Piecing Out Projects Makes Sense

      Getting outside help is a trend both large and small medical device companies are following as outsourcing engineering services continues to gain traction.
      Dawn A. Lissy, President & Founder, Empirical 04.01.20

    • R&D & Design
      Top 10 Considerations for Medtech Inventors

      Top 10 Considerations for Medtech Inventors

      If you or your employer is interested in protecting an invention, then filing a patent application may be the way to go.
      Ryan Connell and Doug Portnow, Schwegman Lundberg & Woessner 04.01.20

    • R&D & Design
      Supercharge Medical Device Innovation Using Effective User Preference Studies

      Supercharge Medical Device Innovation Using Effective User Preference Studies

      User preference and evaluation studies have been a mainstay design tool for medical device development for decades.
      Philip Remedios, Principal, Director of Design & Development, BlackHägen Design 04.01.20


    • R&D & Design | Testing
      FDA Guidelines for Employing X-ray Inspection in Medical Device Development

      FDA Guidelines for Employing X-ray Inspection in Medical Device Development

      Different materials exhibit different radiopacity as a function of material composition (i.e. atomic weight) and thickness.
      Gil Zweig, President, Glenbrook Technologies 01.29.20

    • Digital Health | R&D & Design
      Speed Up or Risk Stepping Down: The New Reality of the Connected Healthcare Development Cycle

      Speed Up or Risk Stepping Down: The New Reality of the Connected Healthcare Development Cycle

      Digital health and connected devices are an extraordinary new tool for delivering on improving patient outcomes.
      Joe McBeth, VP Global Supply Chain, Jabil Healthcare 01.29.20

    • R&D & Design
      Perfecting Drug Delivery Device Design

      Perfecting Drug Delivery Device Design

      Unlike medical products that just need to work, drug delivery devices must also consider intuitiveness, usability, and how it makes the user feel when operated.
      Bryce G. Rutter, Ph.D., Founder & CEO, Metaphase Design Group Inc. 11.04.19


    • R&D & Design
      Best Practices for Industrial Design in the Medical Device Space

      Best Practices for Industrial Design in the Medical Device Space

      This article will outline unique concerns in the medical space and how proper attention to special design considerations is critical.
      Bartosz Korec, Lead Industrial Designer, BlackHägen Design 10.08.19

    • R&D & Design
      Three Crucial Elements of Conducting International Usability Research

      Three Crucial Elements of Conducting International Usability Research

      It is important to conduct usability research throughout the product development cycle.
      Joe Pratt, CHFP, Lead Human Factors Engineer, BlackHägen Design 09.06.19

    • Materials | Packaging & Sterilization | R&D & Design
      Case in Point: Robust Sintered PTFE Material Helps to Reduce Risk of HAIs

      Case in Point: Robust Sintered PTFE Material Helps to Reduce Risk of HAIs

      ...
      Jack Chan, Global Marketing Director—Medical, Porex 07.30.19


    • R&D & Design
      What Is Human Factors Engineering and Why Is It Important?

      What Is Human Factors Engineering and Why Is It Important?

      ...
      Rich Newman, Usability Engineering Manager, BlackHägen Design 07.30.19

    • R&D & Design
      Designing for a Seamless UX

      Designing for a Seamless UX

      ...
      Dr. Bryce Rutter, Founder and CEO, Metaphase Design Group Inc. 06.13.19

    • R&D & Design
      Taking the Waste Out of Product Development

      Taking the Waste Out of Product Development

      ...
      Ron Estes , VP Operations, Estes Design and Manufacturing 05.01.19


    Trending
    • Senseonics Forges Strategic Collaboration With Ascensia Diabetes Care
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Top 10 Trends In The Medical Device And Equipment Industry
    • Masimo Earns CE Mark For New Fingertip Pulse Oximeter
    • At-Home COVID-19 Test Kits Boosts Disease Monitoring Capabilities
    Breaking News
    • Alleviant's Transcatheter Tech Obtains Breakthrough Status
    • Signia Appoints New President
    • At-Home COVID-19 Test Kits Boosts Disease Monitoring Capabilities
    • QT Imaging Signs Distribution Agreement With Freedom Ventures for Breast Scanner
    • MedAcuity, Fathom Partner on Human Factors Engineering Services
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Clinical Evidence Suggests Potential Oral Benefits for Curcumin Extract
    Oleic Acid Possibly Implicated in MS Pathology
    NIH Study Compares Low-Fat, Plant-Based to Low-Carb, Animal-Based Diet
    Coatings World

    Latest Breaking News From Coatings World

    APV Engineered Coatings Reflects on 2020
    LINE-X Launches Dealer Program with International Truck
    BCF CEO to Chair Royal Society of Chemistry Surface Coatings Interest Group
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Alleviant's Transcatheter Tech Obtains Breakthrough Status
    Signia Appoints New President
    At-Home COVID-19 Test Kits Boosts Disease Monitoring Capabilities
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Civica to Build an Essential Medicines Manufacturing Facility in Virginia
    Humanigen, Emergent Enter Covid-19 Partnership
    Samsung Bioepis Opens New Headquarters
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Fitglow Beauty Wins Big at Annual Dirty Thinker’s Choice Awards
    e.l.f. Cosmetics Unveils Mint Melt Collection
    Estée Lauder Companies Updates Supply Chain Leadership
    Happi

    Latest Breaking News From Happi

    Some Good News at Inter Parfums
    Professional Beauty Association Names New Executive Director
    Curcumin's Role in Oral Care
    Ink World

    Latest Breaking News From Ink World

    Paragon Expands Direct Mail Capabilities with Ricoh Pro VC70000
    BOBST Demonstrates Future of Flexible Packaging Production at Virtual Open House
    Morancé Soudure France Adds Comexi F2 MC 10-color Flexo Press
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    VPF launches deep-freeze adhesive
    ProMach strengthens flexible packaging business
    Gallus planning virtual event for March
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Kimberly-Clark Releases Q4, Full Year Results
    Freudenberg to Establish Apparel Interlining Competence Centers
    Minet Adds Spunlace Line in Romania
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    First Patient Implanted With NEXXT MATRIXX SA Cervical Turn-Lock System
    Cretex Companies CEO Steps Down
    Conformis Enters Development & Supply Agreement with SITES Medical
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    First Solar Signs Definitive Agreement to Sell US Development Platform to Leeward
    Imec Technology Taking Off to Space
    North American Semiconductor Equipment Industry Posts December 2020 Billings

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login